Walk Again is a next-generation network of neuro-rehabilitation and neuro-recovery centers, combining innovative technology, evidence-based clinical protocols, and personalised patient care. The platform is built around three demand drivers: rising incidence of stroke, traumatic brain injury (TBI), and spinal cord injuries; aging demographics; and increasing demand for quality post-acute care — all of which create structural unmet demand in the U.S. rehabilitation market.

The platform's differentiated technology asset is an exclusive U.S. lease arrangement for HAL — the Hybrid Assistive Limb robotic exoskeleton developed by Cyberdyne (Japan). HAL provides clinician-controlled robotic gait and movement rehabilitation, producing measurably better functional outcomes for neuro-recovery patients than conventional physical therapy alone.

The $30M raise funds six centers at $5M each — Phase 1 (June 2026): Princeton NJ, Austin TX, Tampa FL; Phase 2: three additional U.S. markets. The U.S. Rehabilitation Centers and Therapy Services Market was $42.83B in 2024 and is projected to grow at a 6.52% CAGR through 2032 (Data Bridge).

HAL (Hybrid Assistive Limb) is a robotic exoskeleton developed by Cyberdyne Inc. (Japan) — the world's most clinically validated wearable cyborg-type robot for neuro-rehabilitation. HAL reads bioelectric signals from a patient's skin surface to detect neural intent, and provides robotic assistance that closes the brain-muscle feedback loop — driving neuroplasticity and functional recovery.

Walk Again holds an exclusive lease arrangement for HAL U.S. deployment, giving the network a technology moat that no U.S. competitor can directly replicate. HAL is particularly effective for stroke recovery, spinal cord injury rehabilitation, and traumatic brain injury cases — precisely the patient populations underserved by traditional physical therapy approaches.